Epilepsy Talk
Medical Marijuana — What the Experts are Saying
19 Comments
“It doesn’t have a high potential for abuse, and there are very legitimate medical applications. In fact, sometimes Marijuana is the only thing that works… It is irresponsible not to provide the best care we can as a medical community, care that could involve Marijuana. We have been terribly and systematically misled for nearly 70 years in the United States, and I apologize for my own role in that.” — Dr. Sanjay Gupta / Neurosurgeon.
Tags: age-old remedy, alternative, anecdotal evidence, DEA restrictions, doctors', Dr. Orrin Devinsky, Dr. Sanjay Gupta, Dravet Syndrome, help relieve pain and suffering, legitimate medical applications, medical marijuana, non toxic, relief, Research, safe, scientific evidence, success
The Great Debate — Medical Marijuana
17 Comments
Even though the cannabis plant has a long history of medicinal use, with evidence dating back to 2,737 BCE, it’s still a subject of hot controversy.
It appears to be a standing battle between politics and science.
The legality requires proof of medical marijuana’s effectiveness.
Reports of success are anecdotal.
Yet there are no funds for clinical trials and it remains on a back burner for further NIH funding and research.
(Wow. What a surprise!)
Dr. Ben Whalley, who is leading the research at the department of pharmacy at the University of Reading, said: “There was a stigma associated with cannabis that came out from the 60’s and 70’s associated with recreational use, so people have tended not to look at it medicinally as a result.”
But now, some experts are calling for fresh research into the potential of cannabis-like compounds to help alleviate seizures.
Because further evidence has emerged that an ingredient of cannabis could help prevent epileptic seizures.
The Great Debate — Medical Marijuana
50 Comments
Even though the cannabis plant has a long history of medicinal use, with evidence dating back to 2,737 BCE, it’s still a subject of hot controversy.
It appears to be a standing battle between politics and science.
The legality requires proof of medical marijuana’s effectiveness.
Reports of success are anecdotal.
Yet there are no funds for clinical trials and it remains on a back burner for further NIH funding and research.
(Wow. What a surprise!)
About the author
